Norinchukin Bank, The Organon & Co. Transaction History

Norinchukin Bank, The

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$19.27 - $24.63 $108,971 - $139,282	5,655 Added 36.86%	20,998 $436,000
Q1 2023 May 12, 2023	BUY	$21.42 - $32.08 $8,289 - $12,414	387 Added 2.59%	15,343 $360,000
Q4 2022 Feb 13, 2023	SELL	$23.31 - $28.61 $69,790 - $85,658	-2,994 Reduced 16.68%	14,956 $417,000
Q3 2022 Nov 14, 2022	BUY	$23.4 - $34.25 $40,739 - $59,629	1,741 Added 10.74%	17,950 $420,000
Q2 2022 Aug 10, 2022	SELL	$31.66 - $38.9 $224,596 - $275,956	-7,094 Reduced 30.44%	16,209 $547,000
Q1 2022 May 12, 2022	BUY	$30.45 - $39.36 $47,958 - $61,992	1,575 Added 7.25%	23,303 $814,000
Q4 2021 Feb 10, 2022	SELL	$28.67 - $37.13 $3,669 - $4,752	-128 Reduced 0.59%	21,728 $662,000
Q3 2021 Nov 09, 2021	BUY	$28.63 - $35.64 $26,024 - $32,396	909 Added 4.34%	21,856 $717,000
Q2 2021 Aug 11, 2021	BUY	$28.45 - $38.0 $595,942 - $795,986	20,947 New	20,947 $634,000

791

193M

1.71M

865K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $3.79B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Norinchukin Bank, The, based on Form 13F filings with the SEC.

Stay updated on Norinchukin Bank, The with notifications on news.